Screener
SELLAS Life Sciences Group, Inc. SLS Interest Expense
Discontinued — last reported Q1 '26
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The source filing: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001390478-26-000008
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Total operating expenses | 9,252 | 6,063 |
| Loss from operations | (9,252) | (6,063) |
| Non-operating income: | ||
| Interest income | 845 | 250 |
| Total non-operating income | 845 | 250 |
| Net loss | $(8,407) | $(5,813) |
| Per share information: | ||
| Net loss per common share, basic and diluted | $(0.05) | $(0.07) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is SELLAS Life Sciences Group, Inc.'s interest expense?
- SELLAS Life Sciences Group, Inc. (SLS) reported interest expense of $845K in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s interest expense changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s interest expense increased by 238.0% year-over-year, from $250K to $845K.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s interest expense?
- Over 2 years (2023 to 2025), SELLAS Life Sciences Group, Inc.'s interest expense has grown at a 63.9% compound annual growth rate (CAGR), from $525K to $1.41M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about SELLAS Life Sciences Group, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude